Delivery Order SPE2DB22D2005-SPE2DB25FJQN7
- Not listed
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $6,287.40. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive award. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This...
- The Defense Logistics Agency awarded a $1,047.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 12, 2025. This non-set-aside competitive award represents a single delivery order fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,406.00 for Rabavert rabies vaccine with diluents, with performance at the company's facility in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order represents a specific transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,913.05 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of November 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider....
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of June 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,310.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,257.48 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQN7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for Rabavert Rabies Vaccine with diluents, valued at $1,676.64, on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor and critical federal healthcare vendor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The prime IDV enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, medications, and medical devices across multiple therapeutic domains. This delivery order reflects the company's ongoing role in supporting Defense Health Agency operations and other federal healthcare systems through the flexible IDC structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/29/25 |